In a univariable analysis, PD‐L1 positivity was associated with lower lung cancer‐specific (univariable HR = 0.23; 95% confidence interval [CI] = 0.056–0.64; P = 0.0028) and overall (univariable HR = 0.28; 95% CI = 0.11–0.60; P = 0.0005) mortality. This evidence concerns the gene CD274 and lung cancer.